Skip to content
Elicio
Contact
Careers
In the News
Elicio in the News
LinkedIn
Twitter
About
Company Overview
Management Team
Board of Directors
Amphiphile Technology
Lymphatic System Primer
The AMP Platform
Publications
Pipeline & Programs
Pipeline
ELI-002
ELI-004
Other Preclinical Programs
Investors
Overview
News & Events
Stock Information
Corporate Governance
Financial & Filings
IR Resources
Careers
Contact
Elicio in the News
News
July 12, 2019 ||
Boosting engineered T cells
Post navigation
Enhanced CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor
Elicio Therapeutics Presents In Vivo Data for a Universal Amphiphile Vaccine Targeting KRAS-Driven Cancers
